Effects of inhibition of cyclooxygenase-2 by RNA interference on proliferation and apoptosis of human gastric cancer cells: An experimental study with human gastric cancer cells and mice

National Medical Journal of China

Volumn 86, Issue 4, 2006, Pages 266-271

  Wang, Bu Hai ^a   Qian, Wei ^a   Gao, Yuan Jun ^a   Wang, Hua Feng ^a   Hou, Xiao Hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Cyclooxygenase2; RNA interference; Stomach neoplasms

Indexed keywords

CYCLOOXYGENASE 2; MESSENGER RNA; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SIZE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME INHIBITION; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE CONSTRUCT; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INOCULATION; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUDE MOUSE; PLASMID; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STOMACH CANCER; STOMACH CARCINOGENESIS; SURVIVAL RATE; TUMOR VOLUME; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2; FEMALE; GENE THERAPY; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 32244447263     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Corcoran CA, He Q, Huang Y, Sheikh MS. Cyclooxygenase-2 interacts with p53 and interferes with p53-dependent transcription and apoptosis. Oncogene, 2005,24:1634-1640.
2. Yamagishi M, Noda M, Tatsumi Y, et al. Correlation between cyclooxygenase-2, proliferative activity, and mucin phenotype in human advanced gastric cancer. J Gastroenterol, 2004, 39: 1143-1149.
3. Tatsuguchi A, Matsui K, Shinji Y, et al. Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue. Hum Pathol, 2004,35:488-495.
4. Kashfi K, Rigas B. Is COX-2 a 'collateral' target in cancer prevention? Biochem Soc Trans. 2005,33:724-727.
5. Deveraux QL, Aza-Blanc P, Wagner KW, et al. Exposing oncogenic dependencies for cancer drug target discovery and validation using RNAi. Semin Cancer Biol, 2003, 13:293-300.
6. Chinese source. 2003, 20:179-181.
7. Wang W, Bergh A, Damber JE. Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer. Clin Cancer Res, 2005,11:3250-3256.
8. Choi EM, Heo JI, Oh JY, et al. COX-2 regulates p53 activity and inhibits DNA damage-induced apoptosis. Biochem Biophys Res Commun, 2005, 328:1107-1112.
9. Chinese source. 2002, 22:722-725.
10. Chinese source. 2005, 85:2566-2569.
11. Yao M, Zhou W, Sangha S, et al. Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer. Clin Cancer Res, 2005, 11:1618-1628.
12. Shaik MS, Chatterjee A, Singh M. Effect of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of lung tumors and their expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma. Clin Cancer Res, 2004,10:1521-1529.
13. Bresalier RS, Sandler RS, Quan H, et al. Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial. N Engl J Med, 2005, 352:1092-1102.
14. Butz K, Ristriani T, Hengstermann A, et al. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene, 2003, 22:5938-5945.
15. Chen Y, Stamatoyannopoulos G, Song CZ. Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res, 2003, 63:4801-4804.
16. Grzmil M, Thelen P, Hemmerlein B, et al. Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells. Am J Pathol, 2003,163:543-552.
17. Svoboda P, Stein P, Hayashi H, et al. Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA interference. Development, 2000,127:4147-4156.
18. Denkert C, Furstenberg A, Daniel PT, et al. Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference. Oncogene, 2003, 22:8653-8661.